The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-5-((2-(trifluoromethyl)benzyl)oxy)pyridine ID: ALA4293596
PubChem CID: 145987913
Max Phase: Preclinical
Molecular Formula: C21H21F3N4O
Molecular Weight: 402.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: FC(F)(F)c1ccccc1COc1cncc(-c2cnn(C3CCNCC3)c2)c1
Standard InChI: InChI=1S/C21H21F3N4O/c22-21(23,24)20-4-2-1-3-15(20)14-29-19-9-16(10-26-12-19)17-11-27-28(13-17)18-5-7-25-8-6-18/h1-4,9-13,18,25H,5-8,14H2
Standard InChI Key: CUBXWMQDHLVNFN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
15.4344 -9.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4333 -9.9613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1413 -10.3703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8510 -9.9608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8481 -9.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1395 -8.7329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5593 -10.3683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2664 -9.9586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9747 -10.3661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9714 -11.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6789 -11.5891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3870 -11.1794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3830 -10.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6750 -9.9543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0874 -9.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8356 -10.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3793 -9.6598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9671 -8.9541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1687 -9.1282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1905 -9.7410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5253 -10.4875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3347 -10.5703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8153 -9.9090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.4805 -9.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6651 -9.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1451 -11.1904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1449 -11.9340 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
15.4830 -11.7298 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.8070 -11.7301 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 2 0
16 17 1 0
17 18 1 0
18 19 2 0
19 15 1 0
13 15 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
17 20 1 0
26 27 1 0
26 28 1 0
26 29 1 0
3 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 402.42Molecular Weight (Monoisotopic): 402.1667AlogP: 4.47#Rotatable Bonds: 5Polar Surface Area: 51.97Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.12CX LogP: 2.92CX LogD: 0.31Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -1.30
References 1. Lim JW, Kim SK, Choi SY, Kim DH, Gadhe CG, Lee HN, Kim HJ, Kim J, Cho SJ, Hwang H, Seong J, Jeong KS, Lee JY, Lim SM, Lee JW, Pae AN.. (2018) Identification of crizotinib derivatives as potent SHIP2 inhibitors for the treatment of Alzheimer's disease., 157 [PMID:30103190 ] [10.1016/j.ejmech.2018.07.071 ]